- Home
- LZ vs AORT Comparison
LZ vs AORT Comparison
Compare LZ & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LZ | AORT |
|---|---|---|
| Founded | 2001 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2021 | 1993 |
Fundamental Metrics
Financial Performance| Metric | LZ | AORT |
|---|---|---|
| Price | $10.25 | $46.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $11.50 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 1.7M | 382.2K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $727,483,000.00 | $422,646,000.00 |
| Revenue This Year | $13.38 | $15.97 |
| Revenue Next Year | $7.07 | $10.96 |
| P/E Ratio | $85.47 | ★ N/A |
| Revenue Growth | 7.17 | ★ 9.81 |
| 52 Week Low | $6.47 | $21.97 |
| 52 Week High | $12.40 | $48.25 |
Technical Indicators
Market Signals| Indicator | LZ | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 62.60 | 57.96 |
| Support Level | $9.28 | $42.68 |
| Resistance Level | $10.40 | $48.25 |
| Average True Range (ATR) | 0.27 | 1.33 |
| MACD | 0.11 | 0.17 |
| Stochastic Oscillator | 87.63 | 72.35 |
Price Performance
Historical ComparisonAbout LZ LegalZoom.com Inc.
LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.